← Leaderboards
Peggy L Porter
Fred Hutchinson Cancer Research Center
$12,328,744
Attributed
$12,328,744
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$23,295,886 · 12
By mechanism
P50$16,961,585 · 7
R01$4,331,194 · 3
P01$1,568,326 · 1
P30$434,781 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- Christopher I Li$36,171,442
- Nicole D. Urban$6,041,880
- Charles Drescher$9,013,816
- Margaret M Madeleine$13,649,862
- Ziding Feng$59,366,183
Others in their field
Top investigators on “Breast”
- David Heimbrook · Leidos Biomedical Research, Inc.$373,324,203
- Norman Wolmark · Nsabp Foundation, Inc.$299,443,204
- Carol Nesel · Westat$147,274,423
- Richard L Schilsky · University Of Chicago$122,521,723
- Walter John Curran · Thomas Jefferson University$115,541,960
- J Brooks Jackson · Social And Scientific Systems, Inc.$111,373,799
Research focus
BreastMalignant NeoplasmsResearch PersonnelMalignant Breast NeoplasmWomanProgramsGrantFundingLeadershipAnticancer ResearchBaseDiagnosisResourcesMemberResponseTumorInstitutionDetectionClinical TrialsResistanceImageMutationCancer Research ProjectPeer Review
Grant awards (69)
Research Program: Women's Cancer$69,361
P30 · FY2019 · CA · contact PI
Research Program: Women's Cancer$9,134
P30 · FY2019 · CA · contact PI
Research Program: Women's Cancer$7,406
P30 · FY2019 · CA · contact PI
Research Program: Women's Cancer$3,701
P30 · FY2019 · CA · contact PI
Research Program: Women's Cancer$2,888
P30 · FY2019 · CA · contact PI
Research Program: Women's Cancer$69,359
P30 · FY2018 · CA · contact PI
Research Program: Women's Cancer$9,134
P30 · FY2018 · CA · contact PI
Research Program: Women's Cancer$8,332
P30 · FY2018 · CA · contact PI
Research Program: Women's Cancer$7,406
P30 · FY2018 · CA · contact PI
Research Program: Women's Cancer$2,888
P30 · FY2018 · CA · contact PI
Research Program: Women's Cancer$1,234
P30 · FY2018 · CA · contact PI
Research Program: Women's Cancer$103,290
P30 · FY2017 · CA · contact PI
Research Program: Women's Cancer$69,377
P30 · FY2016 · CA · contact PI
Research Program: Women's Cancer$71,271
P30 · FY2015 · CA · contact PI
Seattle Cancer Consortium Breast SPORE$2,150,779
P50 · FY2014 · CA · contact PI
Specimen Acquisition and Pathology$237,818
P50 · FY2014 · CA · contact PI
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke$226,500
P50 · FY2014 · CA · contact PI
RELATIONSHIP OF BREAST CANCER SUBTYPE, RISK FACTORS AND ANCESTRY IN HISPANIC A...$188,847
P50 · FY2014 · CA · contact PI
Developmental Research Program$136,330
P50 · FY2014 · CA · contact PI
Leadership$132,852
P50 · FY2014 · CA · contact PI
Career Development Program$81,145
P50 · FY2014 · CA · contact PI
Seattle Cancer Consortium Breast SPORE$2,031,363
P50 · FY2013 · CA · contact PI
RELATIONSHIP OF BREAST CANCER SUBTYPE, RISK FACTORS AND ANCESTRY IN HISPANIC A...$251,424
P50 · FY2013 · CA · contact PI
Specimen Acquisition and Pathology$227,564
P50 · FY2013 · CA · contact PI
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke$227,240
P50 · FY2013 · CA · contact PI
Developmental Research Program$135,946
P50 · FY2013 · CA · contact PI
Leadership$133,398
P50 · FY2013 · CA · contact PI
Career Development Program$80,914
P50 · FY2013 · CA · contact PI
Seattle Cancer Consortium Breast SPORE$2,300,000
P50 · FY2012 · CA · contact PI
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke$314,841
P50 · FY2012 · CA · contact PI
Specimen Acquisition and Pathology$271,285
P50 · FY2012 · CA · contact PI
RELATIONSHIP OF BREAST CANCER SUBTYPE, RISK FACTORS AND ANCESTRY IN HISPANIC A...$264,149
P50 · FY2012 · CA · contact PI
Developmental Research Program$187,182
P50 · FY2012 · CA · contact PI
Leadership$184,979
P50 · FY2012 · CA · contact PI
Career Development Program$111,412
P50 · FY2012 · CA · contact PI
Seattle Cancer Consortium Breast SPORE$2,185,000
P50 · FY2011 · CA · contact PI
RELATIONSHIP OF BREAST CANCER SUBTYPE, RISK FACTORS AND ANCESTRY IN HISPANIC A...$257,440
P50 · FY2011 · CA · contact PI
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke$232,361
P50 · FY2011 · CA · contact PI
PATHOLOGY$224,804
P01 · FY2011 · CA · contact PI
Specimen Acquisition and Pathology$169,093
P50 · FY2011 · CA · contact PI
Developmental Research Program$137,777
P50 · FY2011 · CA · contact PI
Leadership$136,330
P50 · FY2011 · CA · contact PI
Career Development Program$82,008
P50 · FY2011 · CA · contact PI
Seattle Cancer Consortium Breast SPORE$2,300,000
P50 · FY2010 · CA · contact PI
Cytoplasmic mislocalization of p27Kip1 as a causative factor and prognostic marke$1,023,777
P50 · FY2010 · CA · contact PI
RELATIONSHIP OF BREAST CANCER SUBTYPE, RISK FACTORS AND ANCESTRY IN HISPANIC A...$208,873
P50 · FY2010 · CA · contact PI
PATHOLOGY$152,286
P01 · FY2010 · CA · contact PI
Specimen Acquisition and Pathology$113,638
P50 · FY2010 · CA · contact PI
Developmental Research Program$92,591
P50 · FY2010 · CA · contact PI
Leadership$91,618
P50 · FY2010 · CA · contact PI
Career Development Program$55,111
P50 · FY2010 · CA · contact PI
PATHOLOGY$148,919
P01 · FY2009 · CA · contact PI
Gene Copy Number Changes and Breast Cancer Survival$435,986
R01 · FY2008 · CA · contact PI
PATHOLOGY$144,965
P01 · FY2008 · CA · contact PI
Gene Copy Number Changes and Breast Cancer Survival$429,489
R01 · FY2007 · CA · contact PI
PATHOLOGY$55,198
P01 · FY2007 · CA · contact PI
Gene Copy Number Changes and Breast Cancer Survival$447,628
R01 · FY2006 · CA · contact PI
Gene Copy Number Changes and Breast Cancer Survival$438,619
R01 · FY2005 · CA
Molecular Alterations in Lobular/Ductal Breast Cancer$408,856
R01 · FY2005 · CA
Gene Copy Number Changes and Breast Cancer Survival$460,186
R01 · FY2004 · CA
Molecular Alterations in Lobular/Ductal Breast Cancer$384,342
R01 · FY2004 · CA
Molecular Alterations in Lobular/Ductal Breast Cancer$373,149
R01 · FY2003 · CA
Molecular Alterations in Lobular/Ductal Breast Cancer$369,064
R01 · FY2002 · CA
CORE--PATHOLOGY$280,718
P01 · FY2002 · CA
CYCLIN E EXPRESSION IN HUMAN CANCER$194,625
R01 · FY2002 · CA
CORE--PATHOLOGY$280,718
P01 · FY2001 · CA
CYCLIN E EXPRESSION IN HUMAN CANCER$194,625
R01 · FY2001 · CA
CORE--PATHOLOGY$280,718
P01 · FY2000 · CA
CYCLIN E EXPRESSION IN HUMAN CANCER$194,625
R01 · FY2000 · CA